- Thalidomide, sold
under the
brand names Contergan and
Thalomid among others, is an oral
medication used to
treat a
number of
cancers (e.g.,
multiple myeloma)...
- of 2019. In July 1998,
Celgene received approval from the FDA to
market Thalomid for the
acute treatment of the
cutaneous manifestations of
moderate to...
- is
limited research to
fully support this. Thalidomide, also
known as
Thalomid, was used in the mid-1900s primarily, as a sedative. It is a drug that...
-
chronic (usually a
matter of months)
exposure to thalidomide. "US Label:
Thalomid (thalidomide)
capsule [Celgene Corporation]". DailyMed.
Celgene Corporation...
- Te | Tf–Th | Ti | Tj–Tq | Tra–Tri | Trj–Tz
thalidomide (INN)
Thalitone Thalomid THAM
thebacon (INN)
Theelin thenalidine (INN)
thenium closilate (INN) thenyldiamine...
-
Celgene Corp
patents related to its
cancer drugs Revlimid, Pomalyst, and
Thalomid at issue. However,
Celgene convinced the
Patent Trial and
Appeal Board...
-
fraudulent claims for non-reimbursable uses of its
drugs Revlimid and
Thalomid to
Medicare and
state Medicaid programs. In
addition to
listing off-label...
-
settlement resolved allegations that the
company marketed and sold
cancer drugs Thalomid and
Revlimid for non-FDA
approved uses. In the case US v.
Javaid Perwaiz...
- paid $240
million to
settle allegations it sold and
marketed its
drugs Thalomid and
Revlimid off-label in U.S. ex rel.
Brown v. Celgene, CV 10-03165 (RK)...
-
Medicare fraud/kickbacks
False Claims Act/ Anti-Kickback
Statute 2017 20 16
Thalomid/
Revlimid Celgene Corporation $280,000,000 $280
million (civil only; non-intervened)...
